328 related articles for article (PubMed ID: 15105175)
1. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?
Dwyer T; Stankovich JM; Blizzard L; FitzGerald LM; Dickinson JL; Reilly A; Williamson J; Ashbolt R; Berwick M; Sale MM
Am J Epidemiol; 2004 May; 159(9):826-33. PubMed ID: 15105175
[TBL] [Abstract][Full Text] [Related]
2. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.
Bastiaens MT; ter Huurne JA; Kielich C; Gruis NA; Westendorp RG; Vermeer BJ; Bavinck JN;
Am J Hum Genet; 2001 Apr; 68(4):884-94. PubMed ID: 11254446
[TBL] [Abstract][Full Text] [Related]
3. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma.
Box NF; Duffy DL; Irving RE; Russell A; Chen W; Griffyths LR; Parsons PG; Green AC; Sturm RA
J Invest Dermatol; 2001 Feb; 116(2):224-9. PubMed ID: 11179997
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous melanin density of Caucasians measured by spectrophotometry and risk of malignant melanoma, basal cell carcinoma, and squamous cell carcinoma of the skin.
Dwyer T; Blizzard L; Ashbolt R; Plumb J; Berwick M; Stankovich JM
Am J Epidemiol; 2002 Apr; 155(7):614-21. PubMed ID: 11914188
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.
Kennedy C; ter Huurne J; Berkhout M; Gruis N; Bastiaens M; Bergman W; Willemze R; Bavinck JN
J Invest Dermatol; 2001 Aug; 117(2):294-300. PubMed ID: 11511307
[TBL] [Abstract][Full Text] [Related]
6. Indoor tanning and the MC1R genotype: risk prediction for basal cell carcinoma risk in young people.
Molinaro AM; Ferrucci LM; Cartmel B; Loftfield E; Leffell DJ; Bale AE; Mayne ST
Am J Epidemiol; 2015 Jun; 181(11):908-16. PubMed ID: 25858289
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population.
Stratigos AJ; Dimisianos G; Nikolaou V; Poulou M; Sypsa V; Stefanaki I; Papadopoulos O; Polydorou D; Plaka M; Christofidou E; Gogas H; Tsoutsos D; Kastana O; Antoniou C; Hatzakis A; Kanavakis E; Katsambas AD
J Invest Dermatol; 2006 Aug; 126(8):1842-9. PubMed ID: 16601669
[TBL] [Abstract][Full Text] [Related]
8. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
[TBL] [Abstract][Full Text] [Related]
9. Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk.
Nan H; Qureshi AA; Hunter DJ; Han J
Br J Dermatol; 2008 Aug; 159(2):314-21. PubMed ID: 18510673
[TBL] [Abstract][Full Text] [Related]
10. MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism.
Scherer D; Bermejo JL; Rudnai P; Gurzau E; Koppova K; Hemminki K; Kumar R
Int J Cancer; 2008 Apr; 122(8):1787-93. PubMed ID: 18067130
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
Roberts MR; Asgari MM; Toland AE
Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
[TBL] [Abstract][Full Text] [Related]
12. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
13. MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study.
Cust AE; Goumas C; Holland EA; Agha-Hamilton C; Aitken JF; Armstrong BK; Giles GG; Kefford RF; Schmid H; Hopper JL; Mann GJ; Jenkins MA
Int J Cancer; 2012 Aug; 131(3):E269-81. PubMed ID: 22095472
[TBL] [Abstract][Full Text] [Related]
14. A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.
Han J; Qureshi AA; Nan H; Zhang J; Song Y; Guo Q; Hunter DJ
Cancer Res; 2011 Mar; 71(5):1533-9. PubMed ID: 21270109
[TBL] [Abstract][Full Text] [Related]
15. MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population.
Córdoba-Lanús E; Hernández-Jiménez JG; Medina-Coello C; Espinoza-Jiménez A; González A; Rodríguez-Pérez MD; Carretero-Hernández G; Almeida P; Suárez-Hernández J; Perera-Molinero A; Fernández-de-Misa R
Arch Dermatol Res; 2014 Jan; 306(1):51-8. PubMed ID: 24170137
[TBL] [Abstract][Full Text] [Related]
16. Melanocortin 1 receptor variants and skin cancer risk.
Han J; Kraft P; Colditz GA; Wong J; Hunter DJ
Int J Cancer; 2006 Oct; 119(8):1976-84. PubMed ID: 16721784
[TBL] [Abstract][Full Text] [Related]
17. A case-control study of MC1R variants in Greek patients with basal cell carcinoma: increased risk independently of pigmentary characteristics.
Dessinioti C; Sypsa V; Kypreou K; Dimisianos G; Kodela E; Nikolaou V; Antoniou C; Stratigos AJ
Exp Dermatol; 2015 Jun; 24(6):476-8. PubMed ID: 25809071
[TBL] [Abstract][Full Text] [Related]
18. Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma.
Ferrucci LM; Cartmel B; Molinaro AM; Gordon PB; Leffell DJ; Bale AE; Mayne ST
J Invest Dermatol; 2012 Apr; 132(4):1272-9. PubMed ID: 22158557
[TBL] [Abstract][Full Text] [Related]
19. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
20. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study.
Cust AE; Goumas C; Vuong K; Davies JR; Barrett JH; Holland EA; Schmid H; Agha-Hamilton C; Armstrong BK; Kefford RF; Aitken JF; Giles GG; Bishop D; Newton-Bishop JA; Hopper JL; Mann GJ; Jenkins MA
BMC Cancer; 2013 Sep; 13():406. PubMed ID: 24134749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
